Centene Corp. (CNC) Stock Valuation — PE Analysis

Medical - Healthcare Plans · NYSE

Current Price

$63.78

PE Ratio (TTM)

21.5x

Intrinsic Value

$55.4

-15.1% margin of safety

AI MOAT & RISK ANALYSISCNC

COMPETITIVE MOAT

INVESTMENT RISKS

Base case

CNC base case PE valuation

A base case PE valuation for CNC estimates a fair value of about $55.4 per share, against a current price of $63.78. The model assumes 1.9% annual earnings growth, a 21.55x target PE multiple, and a 10% discount rate.

Intrinsic Value

$55.4

Margin of safety

-15.1%

Expected annual return

-2.8%

Base case assumptions: 1.9% annual earnings growth, 21.55x target PE, 10% discount rate, 5 year projection. Data as of 2026-11-20.

This base case uses default assumptions and is not financial advice. The fair value changes significantly when the target PE or earnings growth rate changes. Open the calculator to set your own assumptions and see the full sensitivity range.

Customize the CNC PE valuation

Adjust the target PE, earnings growth, and discount rate to see how the fair value and margin of safety for Centene Corp. respond.

Open PE Calculator for CNC

Or try DCF Valuation for CNC →

Company Overview

Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.

Financial Metrics — CNC PE Stock Valuation Data

PE Ratio (TTM)

21.5x

PEG Ratio

0.19

Earnings Yield

4.64%

ROE (TTM)

6.8%

Revenue/Share (TTM)

$412.62

Debt/Equity

0.70x

Frequently Asked Questions

What is the PE ratio of CNC?

The trailing twelve-month PE ratio of CNC reflects how much investors pay per dollar of Centene Corp.'s earnings. This metric is most useful when compared to Medical - Healthcare Plans peers and the company's own historical range.

Is CNC overvalued based on PE ratio?

CNC's PE of 21.5x combined with a PEG ratio of 0.19 provides a growth-adjusted perspective. A PEG below 1.0 means the P/E is low relative to the earnings growth rate. Keep in mind that PE-based valuation works best for profitable, mature companies — for high-growth or cyclical Medical - Healthcare Plans, a DCF analysis may be more appropriate.

How do I value CNC stock using PE ratio?

To value Centene Corp. using PE: (1) Compare the current PE (21.5x) against the Medical - Healthcare Plans median to assess relative pricing, (2) check the PEG ratio (0.19) to adjust for growth expectations, (3) review the 5-year PE range to identify where the stock sits historically, and (4) estimate fair value by multiplying a target PE by forward EPS estimates. This relative approach complements DCF's absolute valuation.

What is the PEG ratio of CNC?

CNC's PEG ratio is 0.19, calculated by dividing the PE ratio (21.5x) by the expected earnings growth rate. A PEG below 1.0 means the P/E is low relative to the expected earnings growth rate. Note that PEG accuracy depends on the reliability of growth estimates.

Should I use PE ratio or DCF for CNC stock valuation?

PE ratio gives a quick relative read — how CNC is priced versus Medical - Healthcare Plans peers. DCF provides an absolute value based on projected free cash flows. For the most reliable valuation, use PE as a quick comparability screen and DCF for a deeper fundamental analysis. Each method has blind spots: PE ignores capital structure and cash flow quality, while DCF is sensitive to growth and discount rate assumptions.

Learn More

Related PE Valuations

All Healthcare valuations

P/E and DCF value CNC with different methods and assumptions, so the two conclusions can differ. Compare the DCF intrinsic value.

Price as of 2026-11-20. Financial data from Financial Modeling Prep (trailing twelve months) · Valuation methodology by Charlie Wang.

This is an estimate, not investment advice.

CNC Stock Valuation — Free PE Ratio Analysis & Fair Value